Our Company
Bluesight exists to simplify the top complexities of hospital pharmacies. Through our suite of technologies and a commitment to innovation, we transform disparate and disconnected data into actionable insights and workflows.
We help health systems nationwide optimize operations, prevent safety risks, and enhance their pharmacy’s financial performance.
The Bluesight Vision
By providing Medication Intelligence™ solutions from purchase to patient administration, our customers can worry less about inventory, compliance, and costs – and focus on what matters most: patient care.
Simplify your hospital and pharmacy operations
Operations
Optimize your workflows, inventory, and savings while maximizing your staff’s time.
Automate tedious tasks and ensure efficient, collaborative workflows around inventory management, purchasing, and controlled substance monitoring.
Compliance & Safety
Identify and prevent diversion, noncompliance, and safety risks.
Efficiently investigate potential drug diversion, prevent recalled or expired drugs from reaching patients, ensure GPO compliance, and prepare for audits.
Finance
Reduce your hospital’s annual drug spend and execute total fiscal oversight.
Spend less on drug purchases, significantly reduce waste and expirations, and prevent overcharges.
Company Milestones
2011
With the invention of its RFID solution KitCheck, Bluesight is founded.
2012
The company gained its first two customers: The University of Maryland Medical Center and NYU Langone.
2015
Bluesight begins to offer pre-tagged 503b compounded drugs.
2017
ControlCheck, an AI-powered drug diversion monitoring solution, is launched
2020
Bluesight releases its third solution, CostCheck, which optimizes drug spending
2022
Bluesight reaches 1000+ customers and launches first ever Medication Intelligence Summit.
2023
Thoma Bravo announces a strategic growth investment in Bluesight to support the company’s acquisition of Medacist
2024
Bluesight reaches 2,000+ hospital customers
Our Executive Leadership
Kevin MacDonald
Co-Founder and CEO
Mark Peters
Chief Financial Officer
Vijay Venkatesh
Chief Technology Officer
Jason Vander Meer
Chief Product Officer
Matt McAluney
Chief Revenue Officer
Amy Schartner
VP, People
Jacki McLain
VP of Sales
Wayne Chan
VP of Legal